Cargando...
The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
Background: Although widely used, first-line injectable medicines for the treatment of multiple sclerosis (MS) remain an issue of efficacy and adherence. Recently, new oral medications for MS have contributed to dramatic improvements in MS treatment. This study aims to evaluate the safety and effica...
Guardado en:
| Publicado en: | Curr J Neurol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Tehran University of Medical Sciences
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185589/ https://ncbi.nlm.nih.gov/pubmed/38011404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/cjn.v19i3.5427 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|